REVOLUTIONIZING WOUND CARE, ONE BUBBLE AT A TIME
HPad is a pioneering medical device company focused on revolutionizing wound care through innovative hydrogen gas therapy for bed sores. HPad offers an affordable and effective solution that addresses the needs of millions affected each year, aiming to drastically improve patient comfort and care in healthcare settings.
THE PROBLEM
What Are Bed Sores?
Bed sores are painful wounds that develop due to prolonged pressure on specific areas of the body. They are especially common among elderly and diabetic individuals, frequently occurring on the lower back and feet.
Current Treatment Options
While most bed sores are extremely painful, they are generally not serious and can often be treated with gauze, hydrocolloids, or various patches. In more severe cases, treatments such as oxygen gas therapy or negative pressure wound therapy (NPWT) may be employed. However, bed sores tend to be both painful and chronic, requiring repeated application of these treatments.
Impact on Healthcare
Bed sores affect approximately 2.5 million Americans each year, imposing an annual cost of around $9 to $11 billion on the U.S. healthcare system. Much of this expense arises from extended nursing care, treatment of infections, and complex interventions for severe wounds.
OUR MISSION
At HPad, we strive to be at the forefront of wound care, utilizing innovative gas therapies to revolutionize wound care and provide high-quaity care for patients suffering from pressure injuries. Our commitment goes beyond technology; we aim to restore dignity, comfort, and hope to patients and their families.